Mutation Variants and Co‐Mutations as Genomic Modifiers of Response to Afatinib in HER2‐Mutant Lung Adenocarcinoma

Title
Mutation Variants and Co‐Mutations as Genomic Modifiers of Response to Afatinib in HER2‐Mutant Lung Adenocarcinoma
Authors
Keywords
-
Journal
ONCOLOGIST
Volume -, Issue -, Pages theoncologist.2019-0547
Publisher
Alphamed Press
Online
2019-11-21
DOI
10.1634/theoncologist.2019-0547

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation